Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR8.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR7.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR9.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR6.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR3.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR2.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR4.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR1.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR5.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR25.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR17.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR26.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR45.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR39.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR29.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR10.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR41.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR32.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR22.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR44.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR30.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR42.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR23.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR28.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR18.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR12.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR27.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR19.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR11.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR38.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR43.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR40.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR36.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR21.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR37.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR34.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR31.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR13.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR24.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR14.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR33.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR16.htm
EX-32.1 - CERTIFICATION - MEDICAL INTERNATIONAL TECHNOLOGY INCf10k2012ex32i_medicalint.htm
EX-31.1 - CERTIFICATION - MEDICAL INTERNATIONAL TECHNOLOGY INCf10k2012ex31i_medicalint.htm
10-K - ANNUAL REPORT - MEDICAL INTERNATIONAL TECHNOLOGY INCf10k2012_medicalint.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR35.htm
XML - IDEA: XBRL DOCUMENT - MEDICAL INTERNATIONAL TECHNOLOGY INCR20.htm
v2.4.0.6
Income Taxes
12 Months Ended
Sep. 30, 2012
Income Taxes [Abstract]  
Income Taxes
 
Note 8 –  Income Taxes
 
Deferred income taxes are provided for the tax effects of temporary differences in the reporting of income for financial statement and income tax reporting purposes and arise principally from net operating loss carry-forwards, accrued expenses and basis differences in fixed assets. 
 
The Company’s effective tax rate differs from the Federal statutory rates due to the valuation allowance recorded for the unused net operating loss carry-forwards deferred tax asset. The company has operating losses aggregating approximately $12.8 million, which can be used to reduce future taxable income. Pursuant to ASC 740, we must consider all positive and negative evidence regarding the realization of deferred tax assets, including past operating results and future sources of taxable income. Under the provisions of ASC 740, we determined that the entire net deferred tax asset needed to be reserved given recent losses. The total valuation allowance at September 30, 2012 and 2011 was $13.3million and $$13.0million, respectively.
 
We have adopted the provisions of FIN 48, now under ASC 740. Under ASC 740, the impact of an uncertain tax position taken or expected to be taken on an income tax return must be recognized in the financial statements at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized in the financial statements unless it is more likely than not of being sustained.